Targeting Cell Entry of Enveloped Viruses as an Antiviral Strategy

The entry of enveloped viruses into their host cells involves several successive steps, each one being amenable to therapeutic intervention. Entry inhibitors act by targeting viral and/or cellular components, through either the inhibition of protein-protein interactions within the viral envelope pro...

Full description

Bibliographic Details
Main Authors: Elodie Teissier, François Penin, Eve-Isabelle Pécheur
Format: Article
Language:English
Published: MDPI AG 2010-12-01
Series:Molecules
Subjects:
Online Access:http://www.mdpi.com/1420-3049/16/1/221/
_version_ 1818232821885435904
author Elodie Teissier
François Penin
Eve-Isabelle Pécheur
author_facet Elodie Teissier
François Penin
Eve-Isabelle Pécheur
author_sort Elodie Teissier
collection DOAJ
description The entry of enveloped viruses into their host cells involves several successive steps, each one being amenable to therapeutic intervention. Entry inhibitors act by targeting viral and/or cellular components, through either the inhibition of protein-protein interactions within the viral envelope proteins or between viral proteins and host cell receptors, or through the inhibition of protein-lipid interactions. Interestingly, inhibitors that concentrate into/onto the membrane in order to target a protein involved in the entry process, such as arbidol or peptide inhibitors of the human immunodeficiency virus (HIV), could allow the use of doses compatible with therapeutic requirements. The efficacy of these drugs validates entry as a point of intervention in viral life cycles. Strategies based upon small molecule antiviral agents, peptides, proteins or nucleic acids, would most likely prove efficient in multidrug combinations, in order to inhibit several steps of virus life cycle and prevent disease progression.
first_indexed 2024-12-12T11:12:23Z
format Article
id doaj.art-21223be92d8242c6a656ba27f5c7ab03
institution Directory Open Access Journal
issn 1420-3049
language English
last_indexed 2024-12-12T11:12:23Z
publishDate 2010-12-01
publisher MDPI AG
record_format Article
series Molecules
spelling doaj.art-21223be92d8242c6a656ba27f5c7ab032022-12-22T00:26:16ZengMDPI AGMolecules1420-30492010-12-0116122125010.3390/molecules16010221Targeting Cell Entry of Enveloped Viruses as an Antiviral StrategyElodie TeissierFrançois PeninEve-Isabelle PécheurThe entry of enveloped viruses into their host cells involves several successive steps, each one being amenable to therapeutic intervention. Entry inhibitors act by targeting viral and/or cellular components, through either the inhibition of protein-protein interactions within the viral envelope proteins or between viral proteins and host cell receptors, or through the inhibition of protein-lipid interactions. Interestingly, inhibitors that concentrate into/onto the membrane in order to target a protein involved in the entry process, such as arbidol or peptide inhibitors of the human immunodeficiency virus (HIV), could allow the use of doses compatible with therapeutic requirements. The efficacy of these drugs validates entry as a point of intervention in viral life cycles. Strategies based upon small molecule antiviral agents, peptides, proteins or nucleic acids, would most likely prove efficient in multidrug combinations, in order to inhibit several steps of virus life cycle and prevent disease progression.http://www.mdpi.com/1420-3049/16/1/221/inhibitorsviral entryenveloped virus
spellingShingle Elodie Teissier
François Penin
Eve-Isabelle Pécheur
Targeting Cell Entry of Enveloped Viruses as an Antiviral Strategy
Molecules
inhibitors
viral entry
enveloped virus
title Targeting Cell Entry of Enveloped Viruses as an Antiviral Strategy
title_full Targeting Cell Entry of Enveloped Viruses as an Antiviral Strategy
title_fullStr Targeting Cell Entry of Enveloped Viruses as an Antiviral Strategy
title_full_unstemmed Targeting Cell Entry of Enveloped Viruses as an Antiviral Strategy
title_short Targeting Cell Entry of Enveloped Viruses as an Antiviral Strategy
title_sort targeting cell entry of enveloped viruses as an antiviral strategy
topic inhibitors
viral entry
enveloped virus
url http://www.mdpi.com/1420-3049/16/1/221/
work_keys_str_mv AT elodieteissier targetingcellentryofenvelopedvirusesasanantiviralstrategy
AT francoispenin targetingcellentryofenvelopedvirusesasanantiviralstrategy
AT eveisabellepecheur targetingcellentryofenvelopedvirusesasanantiviralstrategy